Lake Point Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$6K Hold
108
0.01% 145
2019
Q4
$7K Buy
+108
New +$6.18K ﹤0.01% 309
2019
Q1
Sell
-5,263
Closed -$274K 694
2018
Q4
$274K Buy
+5,263
New +$283K 0.1% 112

Other funds holding BMY

Lake Point Wealth Management's BMY Position: Q1 2020 in Review

Lake Point Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2020 at 108 shares worth $6K. The position accounts for 0.01% of the portfolio, ranked #145.

Lake Point Wealth Management first reported a position in BMY in Q4 2018 and has held it in 3 quarters since. The position peaked at $274K in Q4 2018. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Lake Point Wealth Management held 108 shares of Bristol-Myers Squibb worth $6K as of Q1 2020.
  • Lake Point Wealth Management left its Bristol-Myers Squibb share count unchanged in Q1 2020.
  • Bristol-Myers Squibb made up 0.01% of Lake Point Wealth Management's portfolio in Q1 2020, its #145 holding.
  • Lake Point Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 3 quarters since.
  • Lake Point Wealth Management's Bristol-Myers Squibb position peaked at $274K in Q4 2018.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Lake Point Wealth Management's 13F filing for Q1 2020, filed 18 May 2020.